hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-04-26癫痫病的哮喘有什么
- 2022-04-13如何预防炎症 滥用抗生素小心得这种病
- 2022-04-12每个女人都是江湖……
- 2022-04-11治疗类风湿性关节炎/膝骨关节炎的专家共识
- 2022-04-11多关节腔糖皮质激素注射治疗可持续改善JIA患者关节症状
- 2022-04-07JAHA:β阻塞性睡眠呼吸暂停综合征患者夜间心律失常和心率波动
- 治疗类风湿性关节炎/膝骨关节炎的专家共识
- 多关节腔糖皮质激素注射治疗可持续改善JIA患者关节症状
- JAHA:β阻塞性睡眠呼吸暂停综合征患者夜间心律失常和心率波动
- 癫痫猝死:凶手是谁?
- 2013国际抗癫痫联合会抗癫痫药用指南
- A&R: Semaphorin3B 在血清诱导的关节炎模型中发挥核心作用,减少类风湿性关节炎患者
- 十个女人,八个贫血,五种常见的便宜货,让你充满气血
- UCB的Vimpat癫痫新适应症在美国获批
- 月经性癫痫患者妊娠期癫痫控制更好
- 预测癫痫患者再入院风险
- 儿童癫痫的症状是什么?
- Circ Ep:左室肥厚高血压患者新发房颤增加SCD风险
- 女神福利:经前烦躁有救!
- 你的输卵管还漂亮吗?
- JCC:炎性肠病患者的间质和肉芽肿性肺病的发病率
- 精子能吃吗? 子的好处
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- 外阴肿痛不好意思看?说明很受伤!
- 胀痛发生了什么事?
- 冒犯多囊卵巢综合征,身体会有这些变化,不容忽视
- 英国为英国脱欧提供紧急医疗服务
- Pharmaceutics:局部治疗念珠菌感染的脂质体槲皮素和无食子酸
- 38癫痫患者年病史上的感谢信 道出了浓浓的医患情况
- 滴虫性阴炎症状 这些表现是滴虫性阴炎
- Medpage Today:不同类型的抗癫痫药物更有利
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 《中国慢性疾病防治基层医生诊疗手册:神经病学分册》定稿印行
- 脑梗的腹泻有哪些 有了这些前兆要谨慎
- 迈瑞、瑞普等大企业重点布局,新瑞鹏融资额领跑,宠物医疗迎来结束丨2020年度盘点
- 老年人爱打瞌睡、喜欢“回忆往事”,还要注意这种状况!
- 癫痫病的前期有什么病因
- 枕叶癫痫的得病类型 枕叶癫痫的临床症状
- 天麻的好处 天麻这些见识你都知道吗
- NMPA:2021年获批准上市的创新止痛
- 药企实验室(研制出/QC)规范管理与 ICH指南及药典最新进展
- 妇女癫痫传染病的关键
- 引致癫痫病发病原因有什么
- 出有为什么要定期复查
- 治疗癫痫病同样的方法是什么
- 得了痉挛会有什么症状